Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Curcumin for Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Arthropathy - A Randomized, Double-Blinded, Controlled Pilot Study

NCT03865992 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT03865992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03865992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Curcumin for Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Arthropathy - A Randomized, Double-Blinded, Controlled Pilot Study
Lead sponsor
City of Hope Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 4, 2019
Completion date
August 4, 2027
Enrollment
42 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, joint pain